Sign in
QNRX Stock Price, Chart, Stats & News
Quoin Pharmaceuticals, Ltd.
Save
9.28M
Market cap
–
Current P/E
–
Forward P/E
QNRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -77.51% |
ROE | -481.59% |
D/E | – |
Interest coverage ratio | – |
QNRX valuation
P/E | – |
P/S | – |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | 0.00x |
EV multiple | -236.32x |
About
Quoin Pharmaceuticals, Ltd. operates as a specialized pharmaceutical firm, concentrating its efforts on devising therapeutic solutions for rare and orphan medical conditions. Its flagship offering, QRX003, is a topical lotion specifically formulated to address Netherton Syndrome. Furthermore, the company is advancing QRX004 for the management of dystrophic epidermolysis bullosa, alongside QRX006, a prospective therapy for an additional rare dermatological ailment.
Similar securities
Based on sector and market capitalization
Report issue